Diffúz nagy B-sejtes limfóma (DLBCL) trials, also abroad
347 open Diffúz nagy B-sejtes limfóma (DLBCL) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Kína | 133 |
| Egyesült Államok | 131 |
| Olaszország | 35 |
| Franciaország | 27 |
| Spanyolország | 25 |
| All other countries |
The same trial often runs in several countries
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) has 7 sites in Mexikó and runs in 35 countries. If a site near you is full, another one may still take people.
See A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) in all 35 countries